The implantable cardioverter-defibrillator: An update

被引：12
|
作者：
Miller, Jared D. [1 ]
Yousuf, Omair [1 ]
Berger, Ronald D. [1 ]
机构：
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
来源：
TRENDS IN CARDIOVASCULAR MEDICINE | 2015年 / 25卷 / 07期
关键词：
CARDIAC-RESYNCHRONIZATION THERAPY; ASSOCIATION TASK-FORCE; GUIDELINES WRITING COMMITTEE; DEVICE-BASED THERAPY; VENTRICULAR-ARRHYTHMIAS; AMERICAN-COLLEGE; AUTOMATIC DEFIBRILLATOR; DILATED CARDIOMYOPATHY; INAPPROPRIATE THERAPY; RHYTHM ABNORMALITIES;
D O I：
10.1016/j.tcm.2015.01.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The implantable cardioverter-defibrillator (ICD) provides life-saving therapy to prevent sudden cardiac death. ICDs have been implanted in millions of patients worldwide since the first human implant in 1980. Clinical trials have helped establish guidelines for ICD implantation in primary and secondary prevention of sudden cardiac death. Recent trials have also tested and compared various programing strategies to avoid unnecessary shocks and improve survival among ICD recipients. IIDs may also assist with monitoring for heart failure management. In this review, we discuss the clinical science to date that has helped define the role of IlDs in current practice. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码：606 / 611
页数：6
相关论文
共 50 条
12345